Clinical Trials Logo

Clinical Trial Summary

This is a therapeutic trial study to demonstrate whether Goserelin, a LHRH agonist has benefit in SBMA

Objective:

1. To study effects of Goserelin to clinical course of patients with spinal and bulbar muscular atrophy in Thailand

2. To demonstrate physiological and pathological changes in treated patients with Goserelin.

3. To assess tolerability and adverse effect of Goserelin therapy


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00851461
Study type Interventional
Source Ramathibodi Hospital
Contact
Status Completed
Phase Phase 4
Start date April 2008
Completion date November 2013

See also
  Status Clinical Trial Phase
Completed NCT00303446 - Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) Phase 2
Recruiting NCT06411912 - A Study of NIDO-361 in Patients With SBMA Phase 2
Completed NCT03560661 - Acoustic and Perceptual Markers of Dysarthria in Amyotrophic Lateral Sclerosis (ALS)
Active, not recruiting NCT05517603 - A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients Phase 1/Phase 2